Skip to content

Efficacy of Adjuvant Cerebellar Theta Transcranial Alternating Current Stimulation In Cognitive Symptoms of Schizophrenia

Efficacy of Adjuvant Cerebellar Theta Transcranial Alternating Current Stimulation In Cognitive Symptoms of Schizophrenia: An EEG-Based Randomized Sham-Controlled Trial - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/05/086093
Enrollment
40
Registered
2025-05-01
Start date
Unknown
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F20- Schizophrenia

Interventions

Intervention1: Theta Transcranial Alternating Current Stimulation (tACS), Active: The Strastim 32 (Neuroelectrics) is a wearable device that wirelessly transmits the 32-channel data via Wi-Fi. Its hyb

Sponsors

Central Institute of Psychiatry
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Diagnosis of schizophrenia (6A20) according to International Classification of Diseases, Eleventh Revision (ICD-11), World Health Organization (WHO). 2. Patients willing to give informed consent. 3. Patients aged between 18-60 years of either sex. 4. Illness duration of more than 2 years. 5. MoCA score less than or equal to 25.

Exclusion criteria

Exclusion criteria: 1. Presence of comorbid neurological or other psychiatric disorder. 2. Presence of comorbid substance use in dependence pattern, except nicotine and caffeine. 3. Patients who have received ECT in past 6 month. 4. Patients not ready to give informed consent.

Design outcomes

Primary

MeasureTime frame
Change in cognitive symptoms in schizophrenia in CANTAB after 20 sessions of theta tACS.Timepoint: Change in cognitive symptoms in schizophrenia in CANTAB after 20 sessions of theta tACS measured at baseline, at 2 weeks and at 6 weeks

Secondary

MeasureTime frame
Change in relative theta power in EEG after 20 sessions of theta tACS.Timepoint: Change in relative theta power will be noted by measuring at baseline & at 6 weeks.

Countries

India

Contacts

Public ContactAniruddha Mukherjee

Central Institute of Psychiatry

dr_aniruddha@hotmail.com9474413598

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026